Menopause Linked to Accelerated Decline in Lung Function

This article originally appeared here.
Share this content:
Menopause Linked to Accelerated Decline in Lung Function
Menopause Linked to Accelerated Decline in Lung Function

WEDNESDAY, April 19, 2017 (HealthDay News) -- Menopause is associated with accelerated decline in lung function, according to a study published in the April 15 issue of the American Journal of Respiratory and Critical Care Medicine.

Kai Triebner, from the University of Bergen in Norway, and colleagues examined whether lung function decline is accelerated in women experiencing menopause. Serum samples, spirometry, and questionnaire data about respiratory and reproductive health were obtained from three study waves of the population-based longitudinal European Community Respiratory Health Survey for 1,438 women. The correlations between menopausal status and lung function decline were assessed, with adjustment for confounding variables, including age, height, weight, pack-years, and current smoking.

The researchers observed a correlation for menopausal status with accelerated decline in lung function. Compared with women menstruating regularly, in transitional and postmenopausal women, the adjusted mean forced vital capacity (FVC) decline increased by −10.2 and −12.5 mL/year, respectively. For transitional and postmenopausal women, the adjusted mean forced expiratory volume in one second decline increased by −3.8 and −5.2 mL/year, respectively.

"Lung function declined more rapidly among transitional and postmenopausal women, in particular for FVC, beyond the expected age change," the authors write. "Clinicians should be aware that respiratory health often deteriorates during reproductive aging."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Actemra to Treat Giant Cell Arteritis

FDA Approves Actemra to Treat Giant Cell Arteritis

New indication provides the first FDA-approved therapy specific to this type of vasculitis

Trends in Teen Binge Drinking Still Raise Concerns

Trends in Teen Binge Drinking Still Raise Concerns

Even though frequent binge drinking among adolescents has dropped in past 25 years

ATS: First Abx Rx Doesn't Work for 25 of Pneumonia Cases

ATS: First Abx Rx Doesn't Work for ~25% ...

One in four adult patients do not respond to initial prescription of antibiotic treatment

is free, fast, and customized just for you!

Already a member?

Sign In Now »